⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VERU News
Veru Inc.
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL
ER+/ HER2 - ve Breast Cancer Market Insight, Epidemiology, and Market Forecast Report 2022-2036
globenewswire.com
AZN
LLY
PFE
GILD
VERU
Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight
globenewswire.com
EDSA
VERU
PLTR
HLIO
DRCT
BHVN
CART
AMGN
AROW
AZN
GSK
NVS
SNDX
SNY
UNH
VRTX
Form 8-K
sec.gov
VERU
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
globenewswire.com
VERU
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
VERU
Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress
globenewswire.com
VERU
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
globenewswire.com
VERU
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
globenewswire.com
VERU
Veru to Report Fiscal Year 2025 Financial Results on December 17th
globenewswire.com
VERU